HomeIDP • ETR
add
Biogen Inc
Nakaraang pagsara
€154.75
Sakop ng araw
€151.35 - €154.05
Sakop ng taon
€146.40 - €245.60
Market cap
23.39B USD
Average na Volume
398.00
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Sa balita
Mga Financial
Income Statement
Kita
Net na kita
| (USD) | Set 2024info | Y/Y na pagbabago |
|---|---|---|
Kita | 2.47B | -2.55% |
Gastos sa pagpapatakbo | 1.32B | -17.78% |
Net na kita | 388.50M | 670.48% |
Net profit margin | 15.76 | 685.87% |
Kita sa bawat share | 4.08 | -6.42% |
EBITDA | 694.20M | 75.52% |
Aktuwal na % ng binabayarang buwis | 13.86% | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (USD) | Set 2024info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 1.70B | -25.73% |
Kabuuang asset | 28.31B | 0.43% |
Kabuuang sagutin | 11.95B | -12.83% |
Kabuuang equity | 16.36B | — |
Natitirang share | 145.72M | — |
Presyo para makapag-book | 1.38 | — |
Return on assets | 4.64% | — |
Return on capital | 5.61% | — |
Cash Flow
Net change in cash
| (USD) | Set 2024info | Y/Y na pagbabago |
|---|---|---|
Net na kita | 388.50M | 670.48% |
Cash mula sa mga operasyon | 935.60M | 57.93% |
Cash mula sa pag-invest | -1.18B | 32.21% |
Cash mula sa financing | -6.60M | -100.78% |
Net change in cash | -209.70M | 36.44% |
Malayang cash flow | 997.75M | 617.87% |
Tungkol
Biogen Inc. is an American multinational biotechnology company based in Cambridge, Massachusetts, United States specializing in the discovery, development, and delivery of therapies for the treatment of neurological diseases to patients worldwide. Biogen operates in Argentina, Brazil, Canada, China, France, Germany, Hungary, India, Italy, Japan, Mexico, Netherlands, Poland, Sweden, and Switzerland. Wikipedia
Itinatag
1978
Headquarters
Website
Mga Empleyado
7,570
